2017-03-06 EINSTEIN CHOICE Study with Bayer’s Rivaroxaban Accepted for Late-Breaking Clinical Trial Presentation at ACC.17
2016-06-03 Bayer and Orion Expand Clinical Development Program With New Phase III Study ARASENS for BAY-1841788 (ODM-201) in Prostate Cancer
2016-05-04 Phase III Trial of Regorafenib in Patients with Unresectable Liver Cancer Meets Primary Endpoint of Improving Overall Survival
2015-09-24 Bayer’s Xarelto® Approved in Japan for the Treatment and Secondary Prevention of Pulmonary Thromboembolism and Deep Vein Thrombosis
2015-09-18 Three-Year Results with EYLEA Show Sustained Improvement in Vision for People with Diabetic Macular Edema
